Literature DB >> 21282718

Myelodysplastic syndromes with bone marrow fibrosis.

Matteo Giovanni Della Porta, Luca Malcovati.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21282718      PMCID： PMC3031682          DOI： 10.3324/haematol.2010.039875

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes.

Authors:  David Bowen; Dominic Culligan; Simon Jowitt; Stephen Kelsey; Ghulam Mufti; David Oscier; Jane Parker
Journal:  Br J Haematol       Date:  2003-01       Impact factor: 6.998

2.  Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.

Authors:  Nicolaus Kröger; Tatjana Zabelina; Anja van Biezen; Ronald Brand; Dietger Niederwieser; Rodrigo Martino; Zi Yi Lim; Francesco Onida; Christoph Schmid; Laurent Garderet; Marie Robin; Michael van Gelder; Reinhard Marks; Argiris Symeonidis; Guido Kobbe; Theo de Witte
Journal:  Haematologica       Date:  2010-10-22       Impact factor: 9.941

Review 3.  Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres.

Authors:  David J Kuter; Barbara Bain; Ghulam Mufti; Adam Bagg; Robert P Hasserjian
Journal:  Br J Haematol       Date:  2007-11       Impact factor: 6.998

4.  Silver Impregnation of Reticulum in Paraffin Sections.

Authors:  G Gömöri
Journal:  Am J Pathol       Date:  1937-11       Impact factor: 4.307

5.  Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome.

Authors:  Matteo G Della Porta; Luca Malcovati; Corinna Strupp; Ilaria Ambaglio; Andrea Kuendgen; Esther Zipperer; Erica Travaglino; Rosangela Invernizzi; Cristiana Pascutto; Mario Lazzarino; Ulrich Germing; Mario Cazzola
Journal:  Haematologica       Date:  2010-12-06       Impact factor: 9.941

6.  Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity.

Authors:  G Lambertenghi-Deliliers; A Orazi; R Luksch; C Annaloro; D Soligo
Journal:  Br J Haematol       Date:  1991-06       Impact factor: 6.998

7.  Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial.

Authors:  G Buesche; R Hehlmann; H Hecker; H Heimpel; B Heinze; A Schmeil; M Pfirrmann; G Gomez; A Tobler; H Herrmann; M Kappler; J Hasford; T Buhr; H-H Kreipe; A Georgii
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

Review 8.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

9.  Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis.

Authors:  Claudia Vener; Nicola Stefano Fracchiolla; Umberto Gianelli; Rossella Calori; Franca Radaelli; Alessandra Iurlo; Sabrina Caberlon; Giancarla Gerli; Leonardo Boiocchi; Giorgio Lambertenghi Deliliers
Journal:  Blood       Date:  2007-11-20       Impact factor: 22.113

10.  A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

Authors:  Corey S Cutler; Stephanie J Lee; Peter Greenberg; H Joachim Deeg; Waleska S Pérez; Claudio Anasetti; Brian J Bolwell; Mitchell S Cairo; Robert Peter Gale; John P Klein; Hillard M Lazarus; Jane L Liesveld; Philip L McCarthy; Gustavo A Milone; J Douglas Rizzo; Kirk R Schultz; Michael E Trigg; Armand Keating; Daniel J Weisdorf; Joseph H Antin; Mary M Horowitz
Journal:  Blood       Date:  2004-03-23       Impact factor: 22.113
View more
  18 in total

1.  Hypocellular myelodysplastic syndrome with myelofibrosis in acute myeloid leukemia transformation: A case report.

Authors:  Kui Song; Xiaojun Xu; Min Li
Journal:  Oncol Lett       Date:  2015-05-20       Impact factor: 2.967

2.  The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.

Authors:  Bin Fu; Chi Young Ok; Maitrayee Goswami; Wei Xei; Jesse M Jaso; Tariq Muzzafar; Carlos Bueso-Ramos; Srdan Verstovsek; Guillermo Garcia-Manero; L Jeffrey Medeiros; Sa A Wang
Journal:  Ann Hematol       Date:  2013-05-10       Impact factor: 3.673

3.  TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis.

Authors:  Sanam Loghavi; Alyaa Al-Ibraheemi; Zhuang Zuo; Guillermo Garcia-Manero; Mariko Yabe; Sa A Wang; Hagop M Kantarjian; Cameron C Yin; Roberto N Miranda; Raja Luthra; L Jeffrey Medeiros; Carlos E Bueso-Ramos; Joseph D Khoury
Journal:  Br J Haematol       Date:  2015-06-30       Impact factor: 6.998

4.  Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight cases.

Authors:  Hamilton C Tsang; James B Bussel; Susan Mathew; Yen-Chun Liu; Allison A Imahiyerobo; Attilio Orazi; Julia T Geyer
Journal:  Mod Pathol       Date:  2017-01-06       Impact factor: 7.842

5.  Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS.

Authors:  Oscar E Brück; Susanna E Lallukka-Brück; Helena R Hohtari; Aleksandr Ianevski; Freja T Ebeling; Panu E Kovanen; Soili I Kytölä; Tero A Aittokallio; Pedro M Ramos; Kimmo V Porkka; Satu M Mustjoki
Journal:  Blood Cancer Discov       Date:  2021-03-22

Review 6.  [Myelodysplastic syndromes. Epidemiology, molecular and morphological characteristics and risk stratification].

Authors:  A H Schmitt-Graeff; M J Müller; P Fisch
Journal:  Pathologe       Date:  2013-02       Impact factor: 1.011

7.  Myelodysplastic syndrome with myelofibrosis transformed to a precursor B-cell acute lymphoblastic leukemia: a case report with review of the literature.

Authors:  Ayed A Algarni; Mojtaba Akhtari; Kai Fu
Journal:  Case Rep Hematol       Date:  2012-03-29

Review 8.  Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the Clinic.

Authors:  Eugenia Flores-Figueroa; Dita Gratzinger
Journal:  Int J Mol Sci       Date:  2016-04-13       Impact factor: 5.923

9.  Early Improvement in Marrow Fibrosis Following Haploidentical Stem Cell Transplantation for a Patient with Myelodysplastic Syndrome with Bone Marrow Fibrosis.

Authors:  Shuichiro Takahashi; Riko Tsumanuma; Keiko Aizawa; Mitsumasa Osakabe; Kunihiko Maeda; Ejiro Omoto
Journal:  Intern Med       Date:  2016-11-15       Impact factor: 1.271

10.  A case-control study of prevalence of anemia among patients with type 2 diabetes.

Authors:  Samuel Antwi-Bafour; Samuel Hammond; Jonathan Kofi Adjei; Ransford Kyeremeh; Alexander Martin-Odoom; Ivy Ekem
Journal:  J Med Case Rep       Date:  2016-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.